Adjuvant

Abemaciclib Early Breast Cancer V1.0

EC-DH Epirubicin, Cyclophosphamide followed by Docetaxel with Trastuzumab Protocol V1.1

EC (Epirubicin Cyclophosphamide) Adjuvant & Neo-Adjuvant Regimen Protocol V1.0

EC-D with HP Epirubicin, Cyclophosphamide follwed by Docetaxel, Trastuzumab, Pertuzumab Neo-Adjuvant & Adjuvant Protocol V2.1

EC-D Epirubicin, Cyclophosphamide followed by Docetaxel Adjuvant Neo-adjuvant Breast Cancer V1.1

Kadcyla (Trastuzumab Emtansine) Early Breast Cancer and Locally Advanced or Metastatic Breast Cancer Protocol V1.3

Neratinib Adjuvant Treatment Breast Cancer Protocol V1.1

Olaparib BRCA mutated HER2 negative early breast cancer V1.1

Paclitaxel Albumin (Abraxane) Breast Cancer V1.1

Paclitaxel with Dose Dense EC Neoadjuvant Adjuvant Breast Cancer V1.1

Paclitaxel with EC Adjuvant or Neoadjuvant Protocol V1.1

Paclitaxel & Trastuzumab Breast Cancer Protocol V1.2

Pembrolizumab with Carboplatin/Paclitaxel and EC Neoadjuvant Breast Cancer Regimen followed by Adjuvant Pembrolizumab V1.0

T Carbo H - Docetaxel, Carboplatin, Trastuzumab, Adjuvant Protocol V1.1

TCHP-Docetaxel, Carboplatin, Trastuzumab, Pertuzumab Neoadjuvant & Adjuvant Protocol V2.2